Table 1.

Patient characteristics

	Chemotherapy alone (n = 37)	Chemo-immunotherapy (n = 31)
Gender
Male	29	19
Female	8	12
Age (yr)	40-84	42-82
Median	68	67
Performance status
0	5	5
1	26	15
2	3	5
3	3	6
Pathology
Intestinal	13	10
Diffuse	24	21
S-1-based chemotherapy
S-1 alone	12	12
S-1/paclitaxel	4	7
S-1/cisplatin	18	6
PSC	3	6

PSC: Paclitaxel plus S-1/cisplatin combination therapy.